Akiyuki Uzawa

Author PubWeight™ 2.32^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Epstein-Barr virus persistence and reactivation in neuromyelitis optica.	J Neurol Neurosurg Psychiatry	2014	0.79
2	Serum high mobility group box 1 is upregulated in myasthenia gravis.	J Neurol Neurosurg Psychiatry	2014	0.78
3	Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.	Mult Scler	2016	0.76
4	A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells.	Neurotherapeutics	2016	0.75
5	The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement.	J Neuroimmunol	2019	0.75
6	Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis.	J Neurol Sci	2015	0.75
7	Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.	PLoS One	2017	0.75
8	Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.	J Neuroimmunol	2015	0.75
9	Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity.	J Neuroimmunol	2017	0.75
10	Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder.	J Neurol Neurosurg Psychiatry	2017	0.75